IMO it is near worthless to estimate the potential revenues for this company. Too many moving parts, one large deal could completely alter any estimates and being realistic now, the only consistent stream is Emida and that's it. After 3 or more commercial deals than watch as the company issues estimates and how analysts can put a valuation on the company. Until then we wait folks, and hope mgmt lands some mighty contracts.